Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Congress Set To Pass Six-Month Funding Bill, As Sequestration Still Looms

This article was originally published in The Gray Sheet

Executive Summary

Both the pending continuing resolution legislation and the sequestration have potential implications, not only for the funding FDA receives from Congress, but also for contributions from industry user fees.


Related Content

User Fee Limbo: FDA Will Not Have Access To Extra Industry Funds At FY 2013 Start
BD's Vince Forlenza Highlights Sequestration Threat To MedTech Research
Sequestration Threat Looms For 2013 Health Care Spending
FDA Subject To More Oversight Following User Fee Bill Passage



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts